New ‘Double Decker’ Antibody-drug Conjugates Fight Cancer

News   Oct 30, 2017 | Original story from The Scripps Research Institute (TSRI)

 
New ‘Double Decker’ Antibody-drug Conjugates Fight Cancer

Left to right: This is an image of study leaders TSRI Professor William R. Roush, Graduate Student Alex Nanna and TSRI Associate Professor Christoph Rader. Credit: The Scripps Research Institute

 
 
 

RELATED ARTICLES

Antimalarial Drugs Could Offer Clinical Benefit to Cancer Patients

News

Antimalarial drugs chloroquine and hydroxychloroquine could find another use as cancer treatments, according to a new clinical study published in ecancermedicalscience.

READ MORE

Chemists Design More Efficient Microreactor Using 3D Printing

News

Researchers developed an electrochemical microreactor using additive manufacturing technology (commonly known as 3D printing). The newly developed microreactor was tested on synthesis of isoindolinones, which are found in many natural products, pharmaceuticals, and biologically active molecules.

READ MORE

Ocean Floor Mud Reveals Secrets of Past European Climate

News

Samples of sediment taken from the ocean floor of the North Atlantic Ocean have given researchers an unprecedented insight into the reasons why Europe’s climate has changed over the past 3000 years.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Biopharma Cancer Research Cell Science Diagnostics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE